SCHEMBL26570869

SCHEMBL26570869

O=C(O)CNC(=O)c1ccc(-c2ccccc2)c(F)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRC P08575 2/20 0.59
CTSL P07711 1/20 0.59
PTPN13 Q12923 1/20 0.59
USP5 P45974 1/20 0.48
KDM4E B2RXH2 3/20 0.48
ALDH1A1 P00352 3/20 0.48
HPGD P15428 3/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
MAPT P10636 3/20 0.47
HIF1A Q16665 2/20 0.47
SLC22A6 Q4U2R8 2/20 0.47
SLC22A8 Q8TCC7 1/20 0.47
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
EGFR P00533 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
PTGS1 P23219 3/20 0.44
MEN1 O00255 2/20 0.44
PTGS2 P35354 2/20 0.44
KMT2A Q03164 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26572451 0.90 PTPRC (0.51) PTPRCCTSLPTPN13USP5KDM4E
SCHEMBL26116582 0.84 MAPK14 (0.52) PTPRCCTSLPTPN13KDM4EALDH1A1
SCHEMBL26570867 0.83 PTPRC (0.63) PTPRCCTSLPTPN13ALDH1A1HPGD
SCHEMBL438531 0.82 PTPRC (0.59) PTPRCCTSLPTPN13USP5KDM4E
SCHEMBL26113792 0.82 MCHR1 (0.48) PTPRCCTSLPTPN13KDM4EALDH1A1
SCHEMBL342843 0.81 KDM4E (0.56) PTPRCCTSLPTPN13USP5KDM4E
SCHEMBL6989058 0.80 CTDSP1 (0.61) KDM4EALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL30147610 0.80 PTGS1 (0.51) ALDH1A1HPGDSMN1; SMN2MAPTHIF1A
SCHEMBL26118039 0.80 PTPRC (0.88) PTPRCCTSLPTPN13USP5KDM4E
SCHEMBL29195031 0.78 KDM4E (0.53) PTPRCCTSLPTPN13USP5KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023183405-A2 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS ALEXION PHARMACEUTICALS, INC. (US) 2023-09-28 WO disclosed